Epilepsy Archives

News and Trends 24 Oct 2024

Fighting severe epilepsies: A new era for Dravet syndrome treatment?

Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline.

October 24, 2024 - 10 minutesmins - By Jules Adam

The future of epilepsy treatment: pioneering advances and patient-centric care

Epilepsy, one of the most widespread neurological diseases in the world, characterized by recurrent seizures, affects approximately 50 million people globally. In Europe, up to six million people are estimated to be living with the disease. Whilst treatment options have come a long way over the last few decades, clinical practice still shows significant unmet […]

October 15, 2024 - 6 minutesmins - By External Contributor

Podcast 23 Feb 2024

Precision neuromedicine: A new dawn for neurological disorders

This week on our podcast, explore how precision neuromedicine is reshaping neurological care with Rapport Therapeutics.

February 23, 2024

In Depth 31 Jan 2024

New epilepsy drugs: what is in the pipeline?

Find out about the new epilepsy drugs currently in the pipeline, as resistance to current AEDs underscores the need for new treatments.

January 31, 2024 - 6 minutesmins - By Willow Shah-Neville

News and Trends 18 May 2023

New epilepsy study could lead to new treatment options

The mechanisms underlying the pathogenesis of epilepsy, a neurological disorder characterized by excessive electrical activity in the brain, remain unknown. Now, using a novel radiotracer, researchers from Japan have been able to offer insight into the role of AMPAR trafficking in epileptogenesis. The radio tracer is [11C]K-2, the first technology to visualize and quantify α-amino-3-hydroxy-5-methyl-4-isoxazole […]

May 18, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 10 Feb 2023

Europe approves childhood epilepsy treatment

UCB’s FINTEPLA (fenfluramine) oral solution has been approved in the European Union (EU) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) as an add-on therapy to other anti-epileptic medicines for patients two years of age and older. The approval by the European Commission (EC) was based on safety and efficacy data from a […]

February 10, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 8 Dec 2022

Metrion and KCNC1 Foundation announce collaboration to identify therapeutic

Metrion Biosciences Limited, and The KCNC1 Foundation are to collaborate to try and find a therapeutic for children. The KCNC1 Foundation is a not-for-profit organization focused on the development of a treatment for an ultra-rare genetic disorder. Variants of the KCNC1 gene impact Kv3.1 potassium channel function, resulting in neurodevelopmental disorders, which can include progressive […]

December 8, 2022 - 2 minutesmins - By Liza Laws

News and Trends 7 Dec 2022

Neuraxpharm’s expansion into the Netherlands takes it from two to 20 countries in six years

Neuraxpharm Group, a European pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, has announced the establishment of Neuraxpharm Netherlands, increasing its presences from two to 20 countries in six years. The company says the expansion into the Dutch market allows it to continue on its pathway to become the number one […]

December 7, 2022 - 3 minutesmins - By Liza Laws

News and Trends 23 Nov 2022

UCB publishes Lennox-Gastaut syndrome study data

UCB has announced the publication of long-term open-label extension (OLE) study results of FINTEPLA (fenfluramine) CIV in the journal Epilepsia. Long-term efficacy and safety findings showed that FINTEPLA, when added to a patient’s current anti-epileptic treatment regimen for seizures associated with Lennox-Gastaut syndrome (LGS), was effective in reducing the frequency of multiple seizure types and […]

November 23, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 15 Nov 2022

Researchers awarded £2M to develop drugs to prevent epileptic seizures in children

Scientists at Aston University in the U.K. have started work on a project that will look for new drug treatments to prevent the onset of childhood epilepsy. The three-year Medical Research Council (MRC) funded project is a collaboration led by researchers in the College of Health and Life Sciences at Aston University, partnered with Bristol […]

November 15, 2022 - 3 minutesmins - By Jim Cornall

More News! 26 Oct 2022

Neuraxpharm to commercialize device giving early warning of epileptic seizures

A wearable medical device that can give an early warning of an epileptic seizure has been developed by medical device startup, mjn-neuro. Central nervous system (CNS) specialist Neuraxpharm Group entered the digital health market by signing a commercialization agreement with the developer for mjn-SERAS with exclusivity in Europe. With this agreement, Neuraxpharm increases its end-to-end […]

October 26, 2022 - 4 minutesmins - By Liza Laws

News and Trends 10 Aug 2022

Epilepsy drug accepted for review in Canada and Israel

SK Biopharmaceuticals, Co., Ltd. says Health Canada has accepted Paladin Labs Inc.’s filing of a new drug submission (NDS) for cenobamate as an adjunctive therapy for the management of partial-onset seizures in adults with epilepsy who are not satisfactorily controlled with conventional therapy. If Health Canada approves the NDS, Paladin Labs would be able to […]

August 10, 2022 - 2 minutesmins - By Jim Cornall

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Epilepsy

Fighting severe epilepsies: A new era for Dravet syndrome treatment?

The future of epilepsy treatment: pioneering advances and patient-centric care

Precision neuromedicine: A new dawn for neurological disorders

New epilepsy drugs: what is in the pipeline?

New epilepsy study could lead to new treatment options

Europe approves childhood epilepsy treatment

Metrion and KCNC1 Foundation announce collaboration to identify therapeutic

Neuraxpharm’s expansion into the Netherlands takes it from two to 20 countries in six years

UCB publishes Lennox-Gastaut syndrome study data

Researchers awarded £2M to develop drugs to prevent epileptic seizures in children

Neuraxpharm to commercialize device giving early warning of epileptic seizures

Epilepsy drug accepted for review in Canada and Israel

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!